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September 2011918 Abstractslesions were TransAtlantic Inter-Society Consensus (TASC) C and D le-
sions: TASC A, 1; TASC B, 1; TASC C, 11, and TASC D, 7. Seven of 24
limbs had totally occluded stents, and debulking atherectomy was per-
formed before relining in 6 of 24 limbs.Median follow-up after relining with
stent grafts was 595 days (interquartile range, 235-769). Overall 1-year
patient survival was 94%. At 1-year after relining with stent grafts, primary
patency was 62%, primary assisted patency was 79%, and secondary patency
was 79%, respectively.
Conclusions: Treatment of femoropopliteal ISR by relining with stent
grafts is effective and patency rates are superior to those previously reported
for conventional balloon angioplasty. By providing a mechanical barrier to
neointimal hyperplasia, stent grafts prevent the recurrence of ISR, and these
results support the expanded clinical use of stent grafts for the treatment of
ISR.
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Crossing the Inguinal Ligament to Treat Arterial Bleeding and Steno-
sis
Praveen Chandar Balraj, MD,1 Neil Moudgil, MD,2 Josh Eisenberg, MD,2
Matthew J. Dougherty, MD,1 Atul Rao, MD,2 Keith Calligaro, MD,1
1Pennsylvania Hospital, Philadelphia, Pa; 2Thomas Jefferson University
Hospital, Philadelphia, Pa
Objective(s): Placement of arterial endoprostheses across the inguinal
ligament is generally contraindicated for fear of kinking, stent fracture,
occlusion of the device, or occlusion of the deep femoral artery (DFA). We
present a series of patients who underwent insertion of polytetrafluroethyl-
ene (PTFE)-covered nitinol Viabahn® stents (W.L. Gore&Assoc, Flagstaff,
Ariz) crossing the midcommon femoral artery (CFA) who were considered
high-risk for open surgery.
Methods:We treated 16 patients with 17 lesions adjacent to or within
the CFA with covered stents. The endografts originated in the common iliac
in 2, external iliac in 13, or the proximal CFA in 2 and terminated in the
distal CFA in 12, the deep femoral (DFA) in 3, or superficial femoral artery
in 2. Indications for endografts included arterial occlusive disease in 10,
bleeding in 6, and aneurysmal disease in 1, and were placed electively in 10
or as an emergency in 7. Comorbidities favoring endovascular treatment
were high medical risk in 10, previous scarring in 4, morbid obesity in 2, and
dense arterial calcification precluding open surgical repair in 1.
Results: The DFA was deliberately sacrificed in 1 of the 17 lesions. No
major complications were documented after the procedure. All grafts re-
mained patent by duplex ultrasound imaging during a mean follow-up of
12.3 months (range, 1-58 months). Two patients required additional endo-
vascular intervention to treat inflow or outflow stenoses during follow-up,
yielding a primary patency rate of 93.8% at 2 years and 85.9% at 5 years.
Conclusions: These preliminary results suggest that selective place-
ment of Viabahn® endografts across the inguinal ligament to treat arterial
occlusive disease or bleeding is safe, effective, and associated with acceptable
patency rates. This strategy helps avoid complicated open arterial surgery in
high-risk patients with associated multiple medical risk factors or a hostile
scarred groin.
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Objective(s): Mycotic aneurysms and aortovisceral fistula are rare and
potentially fatal conditions representing a considerable therapeutic chal-
lenge. Open repair of these conditions is usually associated with a high
operative mortality and morbidity. Although endovascular aneurysm repair
(EVAR) and thoracic EVAR (TEVAR) have been described, concerns about
persistent infection have made their definite role controversial.
Methods: A retrospective chart review was performed of patients
treated for infected aneurysms and aortovisceral fistula during a 4-year
period.
Results: Between January 2007 and January 2011, 10 patients (7 men,
3 women) were treated. The median age was 77 years (range, 61-84 years).
Seven patients presented with mycotic aneurysms: 4 in the descending
thoracic aorta, and 1 each infrarenal, suprarenal abdominal aorta, and
common iliac artery. Four patients had an aortovisceral fistula, one had an
aortoesophageal fistula, and three had an aortoduodenal fistula. All the
patients had an immediate endovascular repair: 4 TEVAR, 1 hybrid EVAR,
and 5 EVARwith a 100% technical success. Patients with aortovisceral fistula
also had an early esophageal and duodenal repair. Intravenous antibiotics
were given for 1 to 6 weeks, followed by lifelong oral antibiotics in 50% of
surviving patients. Median hospital stay was 23.5 days (range, 4-135 days).
Two patients with aortoduodenal fistula died at a median duration of 27.5
days. All the surviving patients, except those with aortoesophageal fistula,
3
pemained well during a mean follow-up of 9.2 months (range 0.5-43
onths), with no radiographic evidence of graft infection. Three additional
ascular interventions were performed in two survivors. A patient with a
uptured iliac artery aneurysm, after an immediate EVAR and hemorrhage
ontrol, had an early axillofemoral, femorofemoral bypass, followed by
neurysm resection and graft explantation. The patient with an aortoesopha-
eal fistula required a repeat TEVAR and placement of esophageal stent for
ersistent fistula after an open esophageal repair.
Conclusions: EVAR and TEVAR may serve as a bridge to definite
epair in patients with aortovisceral fistula and ruptured mycotic aneurysms.
his modality is an effective and a durable option in high-risk patients with
nfected aortic aneurysms. Operative strategy in these patients should be
ndividualized considering the risk of major surgery.
obotic-Assisted Treatment of Median Arcuate Ligament Syndrome
eil Moudgill, Daniel Relles, MD, Francis Rosato, MD, Atul Rao, MD,
aul DiMuzio, MD, Thomas Jefferson Hospital, Philadelphia, Pa
Objective(s):Median arcuate ligament (MAL) syndrome, the external
ompression of the celiac axis by the MAL resulting in symptoms, can be
ifficult to diagnose and treat. Traditionally, open surgical decompression of
he celiac axis was performed, followed by correction of residual arterial
tenosis. More recently, less invasive methods involving laparoscopic lysis of
he ligament, followed by endovascular treatment of residual stenosis, are
eing used.We describe our initial experience treating this rare disorder with
inimally invasive methods involving the da Vinci SI Robot.
Methods: We prospectively evaluated and treated three patients diag-
osed with MAL syndrome. Preoperative evaluation included duplex ultra-
ound imaging, computed tomography, or magnetic resonance angiogra-
hy. Digital subtraction arteriography with pressure monitoring was also
sed. MAL release and celiac ganglionectomy was then performed using the
a Vinci SI Robot.
Results: Operations took an average of 1.5 hours, with the average of
5minutes for dissection. No intraoperative complications occurred, and no
rocedures were converted to open. Intraoperative blood loss in all patients
